MedicineNet.com
About Us | Privacy Policy | Site Map
October 8, 2008
  MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Health news and views MedTerms medical dictionary  
Font Size
A
A
A


Medication Written by Pharmacists Reviewed by Doctors

Pharmacy Author: Omudhome Ogbru, Pharm.D.
Medical Editor: Jay Marks, M.D.

GENERIC NAME: botulinum toxin type A

BRAND NAME: Botox, Botox Cosmetic

DRUG CLASS AND MECHANISM: Botulinum toxin type A is an injectable neuro-toxin, that is, a toxin that blocks the ability of nerves to make muscles contract. It paralyzes muscles.

To cause muscles to contract, nerves release a chemical, acetylcholine, where they meet muscle cells. The acetylcholine attaches to receptors on the muscle cells and causes the muscle cells to contract or shorten. Botulinum toxin prevents the release of acetylcholine and thereby prevents contraction of the muscle cells. In order to affect the release of acetylcholine, botulinum toxin must be injected into the muscle. Botulinum toxin type A was approved by the FDA in December, 1989.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Vial: Powder, 100 units

STORAGE: Unopened vials of botulinum toxin should be refrigerated at 2-8°C . Reconstituted toxin should be used within 4 hours.

PRESCRIBED FOR: Botulinum toxin is used for the treatment of cervical dystonia (spasm of the muscles of the neck) to reduce abnormal head position and neck pain caused by the muscular spasm. It also is injected into the muscles that control the eyeball for treating strabismus (misaligned or lazy eyes) and the muscles of the eyelid for treating blepharospasm (uncontrollable blinking) associated with a condition called dystonia. Botox cosmetic is used for reducing glabellar lines (frown lines) in adults 65 years of age or younger.

DOSING: Botulinum toxin is giving by injection. Dosing should be individualized, and the lowest effective dose should be used. In a study that investigated the use of botulinum toxin in treating cervical dystonia the median total dose was 236 U divided between the affected muscles.

For the treatment of blepharospasm the recommended initial dose is 1.25 to 2.5 U injected into the medial and lateral pre-tarsal orbicularis oculi, the muscle of the upper and lower eyelid. Effects are seen within three days and peak within one to two weeks. Effects may last up to three months after which the treatment may be repeated. If the initial response is inadequate, the dose may be increased two-fold. Injecting more than 5 U is not increasingly beneficial.

In the treatment of strabismus, the initial dose is 1.25-5 U depending on the severity of the strabismus. Muscle paralysis may occur within one to two days after the injection and may last for 2-6 weeks. Treatment should be assessed every 7-14 days after an injection, and, if there is an adequate response, the same dose can be continued. If the response is not adequate, the dose can be increased two-fold.

The total treatment dose for glabellar lines is 20 units. The lowest effective dose should be used, and treatment should not be more frequent than every three months.

DRUG INTERACTIONS: Administration of botulinum toxin with other agents (e.g. aminoglycosides, curare) that affect neuromuscular function may increase the effect of botulinum toxin.

PREGNANCY: There are no adequate studies of botulinum toxin in pregnant women.

NURSING MOTHERS: Botulinum toxin has not been evaluated in nursing mothers.

SIDE EFFECTS: Side effects of botulinum toxin include allergic reactions, rash, itching, headache, neck pain, difficulty swallowing, shortness of breath, nausea and weakness. Patients also complain of pain and tenderness at the injection site. Patients treated for blepharospasm may experience drooping of the eyelid (ptosis), inflammation of the cornea (keratitis), eye dryness, double vision, tearing and sensitivity to light.

Additional drug information: Botox (botulinum toxin type A) FDA approved labeling at RxList.
http://www.rxlist.com/botox-drug/article.htm


Last Editorial Review: 8/8/2004 12:38:23 PM




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


space Related health and medical articles From the Doctors at MedicineNet.com MedicineNet Doctors recommend space
space
MedicineNet Doctors Recommend
  • Achalasia - Achalasia is a disease of the muscle of the esophagus. Symptoms of achalasia are difficulty swallowing, food sticking in the esophagus, both liquid and solid, chest pain, regurgitation at night when sleeping. Source:MedicineNet
  • Botox - Botox is the brand name of a toxin produced by the bacterium Clostridium botulinum.Small, diluted amounts can be directly injected into specific muscles causing controlled weakening of the muscles. Source:WebMD Medical Reference from The Cleveland Clinic
  • Hyperhidrosis - Read about hyperhydrosis (excessive axillary, palmar, plantar sweating) treatment (antiperspirant, Botox) and causes. Put a stop to sweaty palms (hands) and underarms. Source:MedicineNet
  • Read 25 more botulinum toxin type A related articles ...
Latest Medical News
space

Back to Medications Index

Skin & Beauty

Get beauty tips and body treatments.




Topics Related to botulinum toxin type A, Botox, Botox Cosmetic


botulinum toxin type A
RSS FeedSpecialty RSS       Add to My Yahoo! What is this?

Cellulite Treatment with HeatCellulite Treatment with Heat
Most women over 20 have it and hate it, but the bumpy look of cellulite under the skin isn't easy to erase. But a hot technology may change that. See more WebMD Videos »












Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Search Help | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

HON Code We comply with the HONcode standard for health trust worthy information:
verify here.

©1996-2008 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.